Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
5-fluorouracil + folinic acid (Ulm University)
- Development stage
- Unknown
- Lead developer
- Ulm University
- Modality
- Small Molecules
- Administration
- Intravenous
01
Overview
FUFA is a combination chemotherapy regimen consisting of 5-fluorouracil (5-FU) and folinic acid (FA), also known as leucovorin. 5-fluorouracil is a fluoropyrimidine antimetabolite that acts as a thymidylate synthase (TS) inhibitor, disrupting DNA synthesis. Folinic acid is a reduced form of folic acid that stabilizes the binding of 5-FU to TS, thereby enhancing its cytotoxic activity. This specific regimen was evaluated by the University of Ulm in the FOGT5 Phase II clinical trial, which investigated the feasibility of stratifying patients with advanced or metastasized colorectal cancer based on their intratumoral thymidylate synthase mRNA expression levels to predict treatment response. FUFA represents a standard chemotherapy backbone that has been used for decades in colorectal cancer treatment.
- Other names
- 5-FU/FA5-fluorouracil/leucovorin5-fluorouracil/folinic acidFUFA-University of Ulm-colorectal cancer
02
Targets
TS (Thymidylate synthase)
Beyond the preview
Go deeper on 5-fluorouracil + folinic acid (Ulm University).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on 5-fluorouracil + folinic acid (Ulm University).